Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Ultrasonication-Triggered Ubiquitous Assembly of Magnetic Janus Amphiphilic Nanoparticles in Cancer Theranostic Applications.

Liu X, Peng M, Li G, Miao Y, Luo H, Jing G, He Y, Zhang C, Zhang F, Fan H.

Nano Lett. 2019 Jun 12;19(6):4118-4125. doi: 10.1021/acs.nanolett.9b01524. Epub 2019 Jun 4.

PMID:
31140281
2.

Increased effector γδ T cells with enhanced cytokine production are associated with inflammatory abnormalities in severe hand, foot, and mouth disease.

Shen Y, Pan Z, Zhang L, Xue W, Peng M, Hu P, Xu H, Chen M.

Int Immunopharmacol. 2019 Aug;73:172-180. doi: 10.1016/j.intimp.2018.12.067. Epub 2019 May 15.

PMID:
31100712
3.

A systematic review with meta-analysis: Is ribavirin necessary in sofosbuvir-based direct-acting antiviral therapies for patients with HCV recurrence after liver transplantation?

Xue W, Liu K, Qiu K, Shen Y, Pan Z, Hu P, Peng M, Chen M, Ren H.

Int J Infect Dis. 2019 Jun;83:56-63. doi: 10.1016/j.ijid.2019.03.038. Epub 2019 Apr 5.

4.

Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis.

Zhan Z, Chen Y, Duan Y, Li L, Mew K, Hu P, Ren H, Peng M.

PeerJ. 2019 Mar 22;7:e6645. doi: 10.7717/peerj.6645. eCollection 2019.

5.

Genotyping of Multiple Clinical Samples with a Combined Direct PCR and Magnetic Lateral Flow Assay.

Zhang C, Liu X, Yao Y, Liu K, Hui W, Zhu J, Dou Y, Hua K, Peng M, Wang Z, Vermorken AJM, Cui Y.

iScience. 2018 Sep 28;7:170-179. doi: 10.1016/j.isci.2018.09.005. Epub 2018 Sep 8.

6.

Recovery of circulating CD56dim NK cells and the balance of Th17/Treg after nucleoside analog therapy in patients with chronic hepatitis B and low levels of HBsAg.

Liu N, Liu B, Zhang L, Li H, Chen Z, Luo A, Chen M, Peng M, Yin W, Ren H, Hu P.

Int Immunopharmacol. 2018 Sep;62:59-66. doi: 10.1016/j.intimp.2018.06.043. Epub 2018 Jul 5.

PMID:
29990695
7.

Doxorubicin-Loaded Dextran-Modified GoldMag Nanoparticles for Targeting Hepatocellular Carcinoma.

Li X, Li N, Sidlauskas K, Li H, Zhang C, Peng M, Zhang Q, Hua K, Guo L, Li F, Zhang Y, Chen M, Zhang G, Pan Y, Gao L, Cui Y.

J Biomed Nanotechnol. 2018 Jun 1;14(6):1135-1146. doi: 10.1166/jbn.2018.2547.

PMID:
29843878
8.

Upgrade Combination Response Is Limited by Prolonged Nucelos(t)ide Analogue Therapy in HBeAg-positive Chronic Hepatitis B: A Real-life Study.

Wang Q, Li H, Ding D, Peng M, Ren H, Hu P.

J Clin Transl Hepatol. 2018 Mar 28;6(1):11-17. doi: 10.14218/JCTH.2017.00020. Epub 2017 Sep 30.

9.

Curc-mPEG454, a PEGylated Curcumin Derivative, Improves Anti-inflammatory and Antioxidant Activities: a Comparative Study.

Cheng F, Chen Y, Zhan Z, Liu Y, Hu P, Ren H, Tang H, Peng M.

Inflammation. 2018 Mar;41(2):579-594. doi: 10.1007/s10753-017-0714-2.

PMID:
29234949
10.

PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway.

Liu Y, Cheng F, Luo Y, Zhan Z, Hu P, Ren H, Tang H, Peng M.

Biomed Res Int. 2017;2017:8234507. doi: 10.1155/2017/8234507. Epub 2017 Jul 9.

11.

Diagnostic accuracy of Xpert MTB/RIF for tuberculosis detection in different regions with different endemic burden: A systematic review and meta-analysis.

Li S, Liu B, Peng M, Chen M, Yin W, Tang H, Luo Y, Hu P, Ren H.

PLoS One. 2017 Jul 14;12(7):e0180725. doi: 10.1371/journal.pone.0180725. eCollection 2017. Review.

12.

Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery.

Zhao G, Long L, Zhang L, Peng M, Cui T, Wen X, Zhou X, Sun L, Che L.

Sci Rep. 2017 Jun 13;7(1):3383. doi: 10.1038/s41598-017-03111-2.

13.

Th17/Treg imbalance and increased interleukin-21 are associated with liver injury in patients with chronic severe hepatitis B.

Liu B, Gao W, Zhang L, Wang J, Chen M, Peng M, Ren H, Hu P.

Int Immunopharmacol. 2017 May;46:48-55. doi: 10.1016/j.intimp.2017.02.019. Epub 2017 Mar 1.

PMID:
28259000
14.

Synthesis and Characterization of Curcumin-Functionalized HP-β-CD-Modified GoldMag Nanoparticles as Drug Delivery Agents.

Lian T, Peng M, Vermorken AJ, Jin Y, Luo Z, Van de Ven WJ, Wan Y, Hou P, Cui Y.

J Nanosci Nanotechnol. 2016 Jun;16(6):6258-64.

PMID:
27427699
15.

Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production.

Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, Hu H, Peng M, Hu P, Ren H, Tian Z, Zhang D.

Sci Rep. 2016 May 19;6:26296. doi: 10.1038/srep26296.

16.

Tfh cell-mediated humoral immune response and HBsAg level can predict HBeAg seroconversion in chronic hepatitis B patients receiving peginterferon-α therapy.

Zhang L, Zhang M, Li H, Chen Z, Luo A, Liu B, Chen M, Peng M, Ren H, Hu P.

Mol Immunol. 2016 May;73:37-45. doi: 10.1016/j.molimm.2016.03.011. Epub 2016 Mar 31.

PMID:
27037894
17.

Circulating T follicular helper cells are associated with rapid virological response in chronic hepatitis C patients undergoing peginterferon therapy.

Zhang M, Zhang L, Li H, Chen Z, Luo A, Liu B, Chen M, Peng M, Ren H, Hu P.

Int Immunopharmacol. 2016 May;34:235-243. doi: 10.1016/j.intimp.2016.03.005. Epub 2016 Mar 10.

PMID:
26971227
18.

Dextran-coated superparamagnetic nanoparticles as potential cancer drug carriers in vivo.

Peng M, Li H, Luo Z, Kong J, Wan Y, Zheng L, Zhang Q, Niu H, Vermorken A, Van de Ven W, Chen C, Zhang X, Li F, Guo L, Cui Y.

Nanoscale. 2015 Jul 7;7(25):11155-62. doi: 10.1039/c5nr01382h.

PMID:
26062012
19.

Building nanoSPR biosensor systems based on gold magnetic composite nanoparticles.

Yang D, Ma J, Peng M, Zhang Q, Luo Y, Hui W, Jin T, Cui Y.

J Nanosci Nanotechnol. 2013 Aug;13(8):5485-92.

PMID:
23882783
20.

Polyelectrolyte-coated gold magnetic nanoparticles for immunoassay development: toward point of care diagnostics for syphilis screening.

Yang D, Ma J, Zhang Q, Li N, Yang J, Raju PA, Peng M, Luo Y, Hui W, Chen C, Cui Y.

Anal Chem. 2013 Jul 16;85(14):6688-95. doi: 10.1021/ac400517e. Epub 2013 Jul 1.

PMID:
23735054
21.

A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy.

Chao X, Zhang Z, Guo L, Zhu J, Peng M, Vermorken AJ, Van de Ven WJ, Chen C, Cui Y.

PLoS One. 2012;7(10):e40388. doi: 10.1371/journal.pone.0040388. Epub 2012 Oct 8.

22.

Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation.

Hui W, Shi F, Yan K, Peng M, Cheng X, Luo Y, Chen X, Roy VA, Cui Y, Wang Z.

Nanoscale. 2012 Feb 7;4(3):747-51. doi: 10.1039/c2nr11489e. Epub 2011 Dec 22.

PMID:
22193883
23.

Involvement of liver X receptor alpha in histone modifications across the target fatty acid synthase gene.

Yu H, Wu J, Yang M, Guo J, Zheng L, Peng M, Zhang Q, Xiang Y, Cao J, Shen W.

Lipids. 2012 Mar;47(3):249-57. doi: 10.1007/s11745-011-3635-0. Epub 2011 Dec 8.

PMID:
22160584
24.

Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.

Zeng P, Xu Y, Zeng C, Ren H, Peng M.

Int J Pharm. 2011 Aug 30;415(1-2):259-66. doi: 10.1016/j.ijpharm.2011.05.053. Epub 2011 May 27.

PMID:
21645597
25.

PEG-modified GoldMag nanoparticles (PGMNs) combined with the magnetic field for local drug delivery.

Chao X, Guo L, Zhao Y, Hua K, Peng M, Chen C, Cui Y.

J Drug Target. 2011 Apr;19(3):161-70. doi: 10.3109/10611861003801842. Epub 2010 May 13.

PMID:
20465360
26.

Construction of an HBV DNA vaccine by fusion of the GM-CSF gene to the HBV-S gene and examination of its immune effects in normal and HBV-transgenic mice.

Qing Y, Chen M, Zhao J, Hu H, Xu H, Ling N, Peng M, Ren H.

Vaccine. 2010 Jun 11;28(26):4301-7. doi: 10.1016/j.vaccine.2010.04.023. Epub 2010 Apr 27.

PMID:
20430121
27.

Expression, purification and characterization of Gloydius shedaoensis venom gloshedobin as Hsp70 fusion protein in Pichia pastoris.

Yang D, Peng M, Yang H, Yang Q, Xu J.

Protein Expr Purif. 2009 Aug;66(2):138-42. doi: 10.1016/j.pep.2009.03.003. Epub 2009 Mar 13.

PMID:
19286459
28.

Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection.

Chen M, Zhang D, Zhen W, Shi Q, Liu Y, Ling N, Peng M, Tang K, Hu P, Hu H, Ren H.

J Infect Dis. 2008 Dec 1;198(11):1643-50. doi: 10.1086/593065.

PMID:
18954265
29.

Enhanced gene delivery into skeletal muscles with ultrasound and microbubble techniques.

Zhang Q, Wang Z, Ran H, Fu X, Li X, Zheng Y, Peng M, Chen M, Schutt CE.

Acad Radiol. 2006 Mar;13(3):363-7.

PMID:
16488849
30.

Novel vaccines for the treatment of chronic HBV infection based on mycobacterial heat shock protein 70.

Peng M, Chen M, Ling N, Xu H, Qing Y, Ren H.

Vaccine. 2006 Feb 13;24(7):887-96. Epub 2006 Jan 18.

PMID:
16446013
31.

A Quasi species of the pre-S/S gene and mutations of enhancer II/core promoter/pre-C in mothers and their children infected with hepatitis B virus via mother-to-infant transmission.

Xu H, Peng M, Qing Y, Ling N, Lan Y, Liang Z, Cai D, Li Y, Ren H.

J Infect Dis. 2006 Jan 1;193(1):88-97. Epub 2005 Nov 29.

PMID:
16323136
32.

Ultrasound-mediated microbubble destruction enhances VEGF gene delivery to the infarcted myocardium in rats.

Zhigang W, Zhiyu L, Haitao R, Hong R, Qunxia Z, Ailong H, Qi L, Chunjing Z, Hailin T, Lin G, Mingli P, Shiyu P.

Clin Imaging. 2004 Nov-Dec;28(6):395-8.

PMID:
15531137
33.

Supplemental Content

Loading ...
Support Center